AG Mednet builds on Judi platform to streamline DSMB information

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Jason Butcher)
(Image: Getty/Jason Butcher)

Related tags: Data collection, Data, Data management, Clinical data, Clinical trial

AG Mednet releases Judi DSMB as a solution for securing and automating data safety monitoring board activities and documents.

Judi Data Safety Monitoring Boards (DSMB) built on the foundational software-as-a-service (SaaS) platform Judi to enable streamlining of the DSMB activities and documentation that occur during clinical trial reviews.

DSMB activities such as scheduling, document creation and updating, and finalizing forms, often occur on multiple unsecured platforms. The new platform provides contract research organizations (CROs), sponsors, and regulators a secure place for all the information needed throughout the clinical trial DSMB process.

Abraham Gutman, CEO of AG Mednet told us Judi DSMB, “is a single ‘location’ where different constituencies with different roles can find all the documents related to them and the meetings they attend, where they can communicate in real time with other participants, while maintaining close security and audit logging of all activities and document access throughout the life of the project.”

The Judi platforms offer “at-a-glance aggregated information”​ through dashboards. Judi DSMB also shows countdowns to meetings, statistics of received and outstanding documents, and open document queries.

AG Mednet adds Judi DSMB to its line of SaaS solutions. The company offers automated workflow solutions such as Judi Imaging​ to secure and collect clinical trial imaging data, and Judi Adjudication​ to manage end-to-end clinical event and endpoint adjudication workflows.  

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars